首页> 外文期刊>AIDS >Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals.
【24h】

Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals.

机译:Toll样受体4和toll样受体9的多态性影响HIV-1感染者的血清事件人群的病毒载量。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Toll-like receptors (TLRs) are innate immune sensors that are integral to resisting chronic and opportunistic infections. Mounting evidence implicates TLR polymorphisms in susceptibilities to various infectious diseases, including HIV-1. We investigated the impact of TLR single nucleotide polymorphisms (SNPs) on clinical outcome in a seroincident cohort of HIV-1-infected volunteers. DESIGN: We analyzed TLR SNPs in 201 antiretroviral treatment-naive HIV-1-infected volunteers from a longitudinal seroincident cohort with regular follow-up intervals (median follow-up 4.2 years, interquartile range 4.4). Participants were stratified into two groups according to either disease progression, defined as peripheral blood CD4(+) T-cell decline over time, or peak and setpoint viral load. METHODS: Haplotype tagging SNPs from TLR2, TLR3, TLR4, and TLR9 were detected by mass array genotyping, and CD4(+) T-cell counts and viral load measurements were determined prior to antiretroviral therapy initiation. The association of TLR haplotypes with viral load and rapid progression was assessed by multivariate regression models using age and sex as covariates. RESULTS: Two TLR4 SNPs in strong linkage disequilibrium [1063 A/G (D299G) and 1363 C/T (T399I)] were more frequent among individuals with high peak viral load compared with low/moderate peak viral load (odds ratio 6.65, 95% confidence interval 2.19-20.46, P < 0.001; adjusted P = 0.002 for 1063 A/G). In addition, a TLR9 SNP previously associated with slow progression was found less frequently among individuals with high viral setpoint compared with low/moderate setpoint (odds ratio 0.29, 95% confidence interval 0.13-0.65, P = 0.003, adjusted P = 0.04). CONCLUSION: This study suggests a potentially new role for TLR4 polymorphisms in HIV-1 peak viral load and confirms a role for TLR9 polymorphisms in disease progression.
机译:目的:Toll样受体(TLR)是先天性免疫传感器,对于抵抗慢性和机会性感染至关重要。越来越多的证据表明TLR基因多态性对包括HIV-1在内的各种传染病易感性。我们调查了HIV-1感染志愿者的血清事件队列中TLR单核苷酸多态性(SNP)对临床结果的影响。设计:我们分析了来自于纵向血清事件队列的201名未接受抗逆转录病毒治疗的未感染HIV-1的志愿者的TLR SNP,并定期进行了随访(中位随访时间为4.2年,四分位间距为4.4)。根据疾病进展,将参与者分为两组,定义为外周血CD4(+)T细胞随时间下降,或峰值和设定点病毒载量。方法:通过质量阵列基因分型检测来自TLR2,TLR3,TLR4和TLR9的单倍型标记单核苷酸多态性,并在开始抗逆转录病毒治疗之前确定CD4(+)T细胞计数和病毒载量。使用年龄和性别作为协变量的多变量回归模型评估了TLR单倍型与病毒载量和快速进展的相关性。结果:与高/低峰值病毒载量相比,具有高连锁病毒载量的个体中两个TLR4 SNPs [1063 A / G(D299G)和1363 C / T(T399I)]更为频繁(赔率比为6.65、95) %置信区间2.19-20.46,P <0.001;对于1063 A / G,调整后的P = 0.002)。此外,与高/低设定点相比,高病毒设定点的个体中先前与缓慢进展相关的TLR9 SNP的发生频率更低(优势比为0.29,95%置信区间为0.13-0.65,P = 0.003,调整后的P = 0.04)。结论:这项研究表明TLR4多态性在HIV-1峰值病毒载量中可能具有新的作用,并证实了TLR9多态性在疾病进展中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号